ProQR Therapeutics N.V. buy StockNews.com
Start price
12.03.24
/
50%
€1.81
Target price
12.03.25
-
Performance (%)
-18.43%
Price
28.06.24
€1.56
Summary
This prediction is currently active. The price of ProQR Therapeutics N.V. has decreased since the start of the prediction. Compared to the start price this results in a performance of -18.43%. This prediction currently runs until 12.03.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| ProQR Therapeutics N.V. | 0.321% | 0.321% |
| iShares Core DAX® | 1.175% | -0.931% |
| iShares Nasdaq 100 | 1.232% | 9.715% |
| iShares Nikkei 225® | 1.563% | 3.040% |
| iShares S&P 500 | 0.034% | 5.962% |
Comments by StockNews_com for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for PRQR provided by MarketBeat
Stopped prediction by StockNews_com for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.56
22.06.24
22.06.24
-
22.06.25
22.06.25
-4.56%
28.06.24
28.06.24
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.81
11.05.24
11.05.24
-
11.05.25
11.05.25
-17.67%
28.06.24
28.06.24
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.25
11.11.23
11.11.23
-
11.11.24
11.11.24
18.88%
28.06.24
28.06.24